246 related articles for article (PubMed ID: 31931009)
21. Computational Design of Myristoylated Cell-Penetrating Peptides Targeting Oncogenic K-Ras.G12D at the Effector-Binding Membrane Interface.
Li Z; Buck M
J Chem Inf Model; 2020 Jan; 60(1):306-315. PubMed ID: 31855604
[TBL] [Abstract][Full Text] [Related]
22. The hypervariable region of K-Ras4B is responsible for its specific interactions with calmodulin.
Abraham SJ; Nolet RP; Calvert RJ; Anderson LM; Gaponenko V
Biochemistry; 2009 Aug; 48(32):7575-83. PubMed ID: 19583261
[TBL] [Abstract][Full Text] [Related]
23. K-Ras4B lipoprotein synthesis: biochemical characterization, functional properties, and dimer formation.
Dementiev A
Protein Expr Purif; 2012 Jul; 84(1):86-93. PubMed ID: 22569482
[TBL] [Abstract][Full Text] [Related]
24. Cell type-specific importance of ras-c-raf complex association rate constants for MAPK signaling.
Kiel C; Serrano L
Sci Signal; 2009 Jul; 2(81):ra38. PubMed ID: 19638615
[TBL] [Abstract][Full Text] [Related]
25. Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells.
Lee S; Heinrich EL; Lu J; Lee W; Choi AH; Luu C; Chung V; Fakih M; Kim J
Pancreas; 2016 Feb; 45(2):286-92. PubMed ID: 26262587
[TBL] [Abstract][Full Text] [Related]
26. K-Ras
Feng H; Zhang Y; Bos PH; Chambers JM; Dupont MM; Stockwell BR
Biochemistry; 2019 May; 58(21):2542-2554. PubMed ID: 31042025
[TBL] [Abstract][Full Text] [Related]
27. The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B.
Lu S; Jang H; Nussinov R; Zhang J
Sci Rep; 2016 Feb; 6():21949. PubMed ID: 26902995
[TBL] [Abstract][Full Text] [Related]
28. Targeting the α4-α5 interface of RAS results in multiple levels of inhibition.
Spencer-Smith R; Li L; Prasad S; Koide A; Koide S; O'Bryan JP
Small GTPases; 2019 Sep; 10(5):378-387. PubMed ID: 28692342
[TBL] [Abstract][Full Text] [Related]
29. Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells.
Aksamitiene E; Achanta S; Kolch W; Kholodenko BN; Hoek JB; Kiyatkin A
Cell Signal; 2011 Nov; 23(11):1794-805. PubMed ID: 21726627
[TBL] [Abstract][Full Text] [Related]
30. Phosphatidylinositol 3-kinase requirement in activation of the ras/C-raf-1/MEK/ERK and p70(s6k) signaling cascade by the insulinomimetic agent vanadyl sulfate.
Pandey SK; Théberge JF; Bernier M; Srivastava AK
Biochemistry; 1999 Nov; 38(44):14667-75. PubMed ID: 10545192
[TBL] [Abstract][Full Text] [Related]
31. Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway.
Mazzoni IE; Saïd FA; Aloyz R; Miller FD; Kaplan D
J Neurosci; 1999 Nov; 19(22):9716-27. PubMed ID: 10559381
[TBL] [Abstract][Full Text] [Related]
32. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity.
Elad-Sfadia G; Haklai R; Balan E; Kloog Y
J Biol Chem; 2004 Aug; 279(33):34922-30. PubMed ID: 15205467
[TBL] [Abstract][Full Text] [Related]
33. K-Ras and H-Ras activation promote distinct consequences on endometrial cell survival.
Ninomiya Y; Kato K; Takahashi A; Ueoka Y; Kamikihara T; Arima T; Matsuda T; Kato H; Nishida J; Wake N
Cancer Res; 2004 Apr; 64(8):2759-65. PubMed ID: 15087391
[TBL] [Abstract][Full Text] [Related]
34. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding.
Ting PY; Johnson CW; Fang C; Cao X; Graeber TG; Mattos C; Colicelli J
FASEB J; 2015 Sep; 29(9):3750-61. PubMed ID: 25999467
[TBL] [Abstract][Full Text] [Related]
36. The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions.
Nakhaeizadeh H; Amin E; Nakhaei-Rad S; Dvorsky R; Ahmadian MR
PLoS One; 2016; 11(12):e0167145. PubMed ID: 27936046
[TBL] [Abstract][Full Text] [Related]
37. Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1.
York RD; Molliver DC; Grewal SS; Stenberg PE; McCleskey EW; Stork PJ
Mol Cell Biol; 2000 Nov; 20(21):8069-83. PubMed ID: 11027277
[TBL] [Abstract][Full Text] [Related]
38. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
[TBL] [Abstract][Full Text] [Related]
39. Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt.
Romano D; Matallanas D; Weitsman G; Preisinger C; Ng T; Kolch W
Cancer Res; 2010 Feb; 70(3):1195-203. PubMed ID: 20086174
[TBL] [Abstract][Full Text] [Related]
40. The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas.
Nussinov R; Muratcioglu S; Tsai CJ; Jang H; Gursoy A; Keskin O
Mol Cancer Res; 2015 Sep; 13(9):1265-73. PubMed ID: 26085527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
